Posted: May 27, 2019 Scott Antonia, MD, PhD, was appointed director of the newly formed DCI Center for Cancer Immunotherapy at Duke Cancer Institute. In addition to his leadership role, Dr. Antonia will also serve as professor of medical oncology. In his previous roles at H. Lee Moffitt Cancer Center, he built an active lung cancer…

Posted: May 27, 2019 Charles B. Simone, II, MD, has joined the New York Proton Center, which is opening this spring, as its chief medical officer. In his previous position, Dr. Simone was the medical director of the Maryland Proton Treatment Center and an associate professor of radiation oncology at the University of Maryland School of…

Posted: May 27, 2019 After Scott Gottlieb’s resignation as commissioner of the U.S. Food and Drug Administration (FDA) in early March, the Secretary of Health and Human Services Alex M. Azar II appointed Norman E. Sharpless, MD, as acting commissioner. Dr. Sharpless, a physician–scientist, is currently the director of the National Cancer Institute. In a statement,…

Posted: May 27, 2019 Howard (Jack) West, MD, has moved from the Swedish Cancer Institute in Seattle, where he directed the medical oncology component of thoracic oncology program, to City of Hope, Duarte, Calif, in March 2019. Dr. West, an associate clinical professor of medical oncology and executive director of Employer Services, made the move to…